Decision Diagnostics Corp.
DECN · OTC
12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | |
|---|---|---|---|---|
| Revenue | $1,979 | $2,379 | $2,236 | $1,880 |
| % Growth | -16.8% | 6.4% | 18.9% | – |
| Cost of Goods Sold | $1,481 | $1,529 | $1,929 | $1,950 |
| Gross Profit | $498 | $850 | $307 | -$70 |
| % Margin | 25.2% | 35.7% | 13.7% | -3.7% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $2,310 | $1,728 | $2,160 | $2,295 |
| SG&A Expenses | $2,310 | $1,728 | $2,160 | $2,295 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $290 | $417 | $0 | $0 |
| Operating Expenses | $2,600 | $2,145 | $2,160 | $2,295 |
| Operating Income | -$2,111 | -$1,294 | -$1,853 | -$2,365 |
| % Margin | -106.7% | -54.4% | -82.9% | -125.7% |
| Other Income/Exp. Net | -$27,557 | -$1,838 | -$387 | -$624 |
| Pre-Tax Income | -$29,669 | -$3,132 | -$2,240 | -$2,989 |
| Tax Expense | $0 | $0 | $0 | $2 |
| Net Income | -$29,669 | -$3,132 | -$2,240 | -$2,991 |
| % Margin | -1,499.1% | -131.7% | -100.2% | -159.1% |
| EPS | -0.11 | -0.021 | -0.018 | -0.032 |
| % Growth | -428.8% | -16.2% | 43.5% | – |
| EPS Diluted | -0.11 | -0.021 | -0.018 | -0.032 |
| Weighted Avg Shares Out | 266,563 | 150,368 | 124,990 | 94,244 |
| Weighted Avg Shares Out Dil | 266,563 | 150,368 | 124,990 | 94,243 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $27,263 | $3,016 | $386 | $350 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$2,406 | -$117 | -$1,854 | -$2,639 |
| % Margin | -121.6% | -4.9% | -82.9% | -140.3% |